Jie Wen

Jie Wen is a notable inventor based in Zhenjiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperuricemia and gout. His innovative work has led to the development of a unique compound that addresses these health issues effectively.

Latest Patents

Jie Wen holds 1 patent for his invention titled "Compound for treating or preventing hyperuricemia or gout." This invention discloses a class of compounds that promote uric acid excretion, thereby providing a therapeutic approach to managing hyperuricemia and gout. The compounds are represented in a general formula and include pharmaceutically acceptable salts, making them viable for medical applications.

Career Highlights

Jie Wen is associated with Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work in this company has been pivotal in bringing innovative solutions to the pharmaceutical industry.

Collaborations

Jie Wen has collaborated with notable colleagues, including Dongfang Shi and Changjin Fu. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Jie Wen's contributions to the field of pharmaceuticals, particularly through his patent for treating hyperuricemia and gout, highlight his role as an innovator. His work continues to impact the industry positively, paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.